Diagnosis and Treatment of Genitourinary Malignancies

DIAGNOSTIC Advances: The Use of Molecular Medicine in the Diagnosis and Prognosis of Genitourinary Malignancies.- 1. Epidemiology of prostate cancer and bladder cancer: An Overview.- 2. Von Hippel-Lindau syndrome: hereditary cancer arising from Inherited mutations of the VHL tumor suppressor gene.- 3. New pathologic techniques for diagnosing genitourinary Malignancies.- 4. Reverse transcriptase-polymerase chain reaction (RT-PCR) to detect prostate cancer micrometastasis in the blood.- 5. Successful separation between benign prostatic hyperplasia and prostate cancer by measurement of free and complexed PSA.- Surgical and Radiation Advances.- 6. Retroperitoneal lymphadenectomy in staging and treatment of clinical stage I and II nonseminomatous testis cancer (NSGCT): the development of nerve-sparing techniques.- 7. Current therapy for invasive bladder cancer.- 8. Beyond the nerve-sparing radical prostatectomy.- 9. Three-dimensional conformal therapy (3D-CRT) for prostate cancer.- 10. Cryosurgical ablation of the prostate: treatment alternative for localized prostate cancer.- Medical Advances.- 11. The chemoprevention of prostate cancer and the prostate cancer prevention trial.- 12. Total androgen blockade for prostate cancer: the end does not justify the means.- 13. Therapy for hormone-resistant prostate cancer no longer a myth.- 14. Renal, bladder, and prostate cancers: gene therapy.- 15. The role of immunotherapy in urologic malignancies.- 16. Assessing health-related quality of life in patients with genitourinary malignancies.